newsfilter
← Latest News
GlobeNewswire·

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Key IP Portfolio Advancements Align with Biotech Asset Trend

NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- Oncotelic Therapeutics Inc. (OTCQB:OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic